Evidence map›Paper›PMID 34048815›Full record

ReviewInternational journal of radiation oncology, biology, physics2021

Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.

Robert W Mutter, J Isabelle Choi, Rachel B Jimenez, Youlia M Kirova, Marcio Fagundes, Bruce G Haffty, Richard A Amos, Julie A Bradley, Peter Y Chen, Xuanfeng Ding and 11 more

Abstract readReviewConsensus Statement
In one paragraph

Review in International journal of radiation oncology, biology, physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Cardiac substructure dosimetry in thoracic radiotherapy: moving beyond mean heart dose and toward precision cardiac risk mitigation.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Towards proton therapy guidelines for radiation therapists and dosimetrists: A scoping review.Technical innovations & patient support in radiation oncology · 2025
    Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Robert W MutterDepartment of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. Electronic address: mutter.robert@mayo.edu.
J Isabelle ChoiDepartment of Radiation Oncology, New York Proton Center and Memorial Sloan Kettering Cancer Center, New York, New York.
Rachel B JimenezDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Youlia M KirovaDepartment of Radiation Oncology, Institut Curie, Paris, France.
Marcio FagundesDepartment of Radiation Oncology, Miami Cancer Institute, Miami, Florida.
Bruce G HafftyDepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Richard A AmosProton and Advanced Radiotherapy Group, Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
Julie A BradleyDepartment of Radiation Oncology, University of Florida, Jacksonville, Florida.
Peter Y ChenDepartment of Radiation Oncology, Beaumont Health, Royal Oak, Michigan.
Xuanfeng DingDepartment of Radiation Oncology, Beaumont Health, Royal Oak, Michigan.
Antoinette M CarrDepartment of Radiation Oncology, Beaumont Health, Royal Oak, Michigan.
Leslie M TaylorDepartment of Radiation Oncology, Beaumont Health, Royal Oak, Michigan.
Mark PankuchDepartment of Radiation Oncology, Northwestern Medicine Proton Center, Warrenville, Illinois.
Raymond B Mailhot VegaDepartment of Radiation Oncology, University of Florida, Jacksonville, Florida.
Alice Y HoDepartment of Radiation Oncology, New York Proton Center and Memorial Sloan Kettering Cancer Center, New York, New York.
Petra Witt NyströmThe Skandion Clinic, Uppsala, Sweden and the Danish Centre for Particle Therapy, Aarhus, Denmark.
Lisa A McGeeDepartment of Radiation Oncology, Mayo Clinic Hospital, Phoenix, Arizona.
James J UrbanicDepartment of Radiation Medicine and Applied Sciences, UC San Diego Health, Encinitas, California.
Oren CahlonDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
John H MaduroDepartment of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Shannon M MacDonaldDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.

Funding

Mayo Clinic Interdisciplinary Women's Health Research ProgramK12HD065987 · NICHD · MAYO CLINIC ROCHESTER · PI KANTARCI, KEJAL · 2010 to 2023
$6.7M
NICHD NIH HHS K12 HD065987
6 · The paper itself

Abstract

Radiation therapy plays an important role in the multidisciplinary management of breast cancer. Recent years have seen improvements in breast cancer survival and a greater appreciation of potential long-term morbidity associated with the dose and volume of irradiated organs. Proton therapy reduces the dose to nontarget structures while optimizing target coverage. However, there remain additional financial costs associated with proton therapy, despite reductions over time, and studies have yet to demonstrate that protons improve upon the treatment outcomes achieved with photon radiation therapy. There remains considerable heterogeneity in proton patient selection and techniques, and the rapid technological advances in the field have the potential to affect evidence evaluation, given the long latency period for breast cancer radiation therapy recurrence and late effects. In this consensus statement, we assess the data available to the radiation oncology community of proton therapy for breast cancer, provide expert consensus recommendations on indications and technique, and highlight ongoing trials' cost-effectiveness analyses and key areas for future research.

Indexed as

BreastBreast NeoplasmsConsensusCost-Benefit AnalysisFemaleHumansLinear Energy TransferNeoplasm Recurrence, LocalProton TherapyRadiotherapy Planning, Computer-AssistedRelative Biological Effectiveness

Identifiers

PMID34048815
PMCPMC8416711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.